|
⚲
|
| Keyboard |
| Celebi John
✚
|
|
|---|---|
| CIK # | 0001843539 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001843539] | |
| 4 | [0001843539] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Faeth Therapeutics Inc | |
| Celebi John |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2025-02-19 | Tax withheld | 5,558 | $0.48 | 2,668 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 360,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-12-20 | Grant | 355,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2024-02-15 | Tax withheld | 5,891 | $0.79 | 4,654 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-02-15 | Grant | 165,889 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2024-02-15 | Grant | 315,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-09-11 | Buy | 500 | $0.85 | 425 |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Grant | 51,893 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Tax withheld | 20,492 | $1.50 | 30,738 |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2023-02-15 | Grant | 90,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-02-15 | Grant | 21,300 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2022-02-15 | Grant | 53,900 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2022-02-15 | Grant | 161,600 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2021-02-03 | Grant | 416,666 | $0.00 |